This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Incyte Pharmaceuticals, Inc., Cornell University, National Institute of Health and Medical Research. Active years: 1997-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Foster City, CA (US) (1997)
- 78610 Le Perray, FR (1998)
- Auffargis, FR (1997 - 2011)
Company Filing History:
4 out of 576 
1 out of 2,953 
1 out of 1,853 
Years Active: 1997-2011
Title: Innovations by Pierre-Olivier Couraud: Pioneering Research and Patents in Biomedical Science
Introduction
Pierre-Olivier Couraud is a distinguished inventor based in Auffargis, France. He holds six patents, showcasing his innovative contributions to biomedical research and therapeutics. Couraud’s work predominantly focuses on the development of in vitro models and therapeutic compositions aimed at addressing complex medical conditions.
Latest Patents
Among his most notable patents is the "Human blood brain barrier model," which describes an immortalized human brain endothelial cell line. This invention serves as a vital in vitro model for studying the blood-brain barrier, facilitating advancements in understanding neurological diseases and drug delivery systems. Another significant patent, titled "Method of causing selective immunosuppression using HL-60-related lectins," encompasses pharmaceutical compositions intended for the treatment of autoimmune conditions such as rheumatoid arthritis, myasthenia gravis, and multiple sclerosis. This composition utilizes a soluble lectin that binds to beta-galactoside-containing moieties, thereby modulating immune responses and offering potential in organ or tissue transplant settings.
Career Highlights
Pierre-Olivier Couraud has made substantial impacts during his career, particularly through his affiliations with reputable organizations. He has worked with Incyte Pharmaceuticals, Inc., where he contributed to various research initiatives, and the Institut National De La Santé Et De La Recherche Médicale, which emphasizes his commitment to advancing medical science and therapeutic innovations.
Collaborations
Throughout his professional journey, Couraud has collaborated with esteemed colleagues, including Glenn E. Nedwin and Tim Bringman. These partnerships have facilitated the exchange of ideas and the development of groundbreaking research that pushes the boundaries of biomedical advancements.
Conclusion
Pierre-Olivier Couraud's innovative patents and research contributions highlight his essential role in the field of biomedical science. His work not only enhances our understanding of vital medical conditions but also fosters the development of new therapeutic avenues, reflecting the profound impact of his inventions on patient care and scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile